15
Participants
Start Date
April 30, 2005
Primary Completion Date
October 23, 2010
Study Completion Date
June 11, 2012
PS 341
PS 341 1.6 mg/m2 IV (in the vein) on days 1 and 8 of each 21 day cycle up to 12 cycles.
Docetaxel
Docetaxel 75mg/m2 IV (in the vein) on day 1 of each 21 day cycle up to 12 cycles.
USC/Norris Comprehensive Cancer Center, Los Angeles
Collaborators (1)
Millennium Pharmaceuticals, Inc.
INDUSTRY
University of Southern California
OTHER